Adderal XR, used for ADHD syndrome (attention deficit hyperactiviy disorder) has been withdrawn in Canada because of sudden heart related deaths in children and adults taking recommended doses. The deaths included 14 children and 6 adults and were not due to overdoses. It is still available in the US but the FDA is monitoring carefully. (Feb 11, 05) The FDA has approved Pfizer's Lyrica (pregabalin) capsules for the management of neuropathic pain accompanying postherpetic neualgia including shingles. It is classified as an analgesic and is not a controlled or narcotic drug. (Jan 05) Oxycodone/ibuprofen combo approved to treat moderate to severe pain. Forest Laboratories's Combunox (oxycodone HCL 5 mg and ibuprofen 400 mg) tablets has been approved for short term treatment of acute moderate to severe pain. It is classified as a Schedule II controlled substance. (Dec 04)